Avidity Biosciences vs Tenaya Therapeutics
Avidity Biosciences vs Tenaya Therapeutics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Avidity Biosciences is on 53/100 and Tenaya Therapeutics on 55/100.
Where each one leads
Avidity Biosciences
- agent readiness: 37/100 against 32/100
- headcount: 445 against 99
- funding raised: $495M against $159M
- LinkedIn following: 37,705 against 18,454
Tenaya Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Avidity Biosciences | Tenaya Therapeutics |
|---|---|---|
| What it is | Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases. | Biotechnology company developing gene therapies and regenerative medicine for heart disease. |
| Category | Biotech, Drug Discovery, Genomics, Clinical Trials | Biotech, MedTech, HealthTech, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2013 | 2016 |
| Headquarters | San Diego, United States | South San Francisco, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Avidity Biosciences | Tenaya Therapeutics |
|---|---|---|
| Employees | 445 | 99 |
| Total funding | $495M | $159M |
| Latest round | IPO | Public Offering |
| LinkedIn followers | 37,705 | 18,454 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Avidity Biosciences | Tenaya Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 55/100 |
| Traction | 60/100 | 60/100 |
| Team | Not published | 70/100 |
| Search visibility | 22/100 | 37/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (37/100) | F (32/100) |
| Domain ratingLink authority, 0-100 | 46/100 | 45/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Avidity Biosciences | Tenaya Therapeutics |
|---|---|---|
| Hosting | Self Managed | Google Cloud |
| CMS | Not detected | WordPress |
| Frameworks | Jquery, Bootstrap | Jquery, Tailwind CSS, Bootstrap |
| Analytics | Google Tag Manager | Google Analytics 4 |
Avidity Biosciences vs Tenaya Therapeutics: common questions
Which is better, Avidity Biosciences or Tenaya Therapeutics?
On our 0-100 score Tenaya Therapeutics rates higher (55/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Avidity Biosciences and Tenaya Therapeutics compare on the numbers?
Avidity Biosciences leads on agent readiness (37/100 against 32/100), headcount (445 against 99), funding raised ($495M against $159M), LinkedIn following (37,705 against 18,454).
Read the full Avidity Biosciences review and pricing or the Tenaya Therapeutics review and pricing. You can also browse other Avidity Biosciences alternatives we track.